SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001104659-22-030092
Filing Date
2022-03-03
Accepted
2022-03-03 17:08:02
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B7 tm228298d2_424b7.htm 424B7 409134
2 EX-FILING FEES tm228298d2_ex-filingfees.htm EX-FILING FEES 25146
3 GRAPHIC image_003.jpg GRAPHIC 5284
  Complete submission text file 0001104659-22-030092.txt   442763
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-261888 | Film No.: 22710131
SIC: 2836 Biological Products, (No Diagnostic Substances)